Psychedelic drugs have been on quite the trip. Though they have been used culturally for thousands of years for medicinal and spiritual reasons—from psilocybin-containing mushrooms in Aztec rituals to the iboga plant used by Bwiti shaman in Africa and indigenous Amazonian groups using ayahuasca—their entry into modern chemistry and Western medicine didn’t begin until the […]

As global capital markets brace for uncertainty, the current administration’s tariff policies have introduced a new wave of volatility—sending a ripple effect across sectors and borders. While tariffs have long been used as a geopolitical tool, their resurgence in 2025 can be disruptive for startups and growth-stage companies that rely on market stability and investor […]

Investors look at many variables when deciding which stocks to buy, including a company’s industry. If an industry is exhibiting high growth, stocks in that sector can gain value. It’s similar to how a rising tide can lift all boats, and that trend can play out for psychedelic stocks.

Since the blockbuster release of OpenAI’s ChatGPT in 2022, artificial intelligence (AI) seems to have found its way into every industry, not least the biotech sector, where it has been adopted by numerous companies in the last few years to help with a varying degree of tasks, namely in the drug development process. However, not […]

Every industry has its inflection points—moments where scrutiny intensifies, public perception shifts and the path forward is unclear. For leaders, these moments aren’t just about survival. They’re about recalibrating strategy, maintaining credibility and identifying new opportunities to lead from the front. One recent example that offers broader lessons for executives across sectors comes from the […]

On Tuesday, Enveric Biosciences’ wholly-owned subsidiary, Akos Biosciences, Inc., entered into two licensing agreements with Restoration Biologics LLC, a biotechnology company focused on treating joint disease. The companies have executed two licenses for Akos’ cannabinoid-COX-2 conjugate compounds for pharmaceutical and potential non-pharmaceutical applications.

With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy hitters to compounded varieties, each promises to help shed pounds. But a recent head-to-head trial comparing Zepbound vs. Wegovy provided new insights into their effectiveness, making the choice slightly clearer. The findings? Zepbound led to […]

It is difficult these days to talk about biotech without mentioning the revolutionary role that AI is playing – and will continue to play – in the industry. When making these same predictions last year, we said that AI was likely to be a key biotech trend in 2024. This was most certainly the case, […]

For most of my life, I slept soundly the moment my head hit the pillow. Ever since I moved countries over a year ago, things changed. Sleep didn’t come as easily. Despite feeling adequately tired by bedtime, I’d lie awake, my mind racing with worries about work or conjuring up hypothetical scenarios about my loved […]

Psychedelics biotech company Enveric Biosciences completed preclinical pharmacokinetic (PK) studies for its leading drug candidate EB-003 aimed at treating depression and anxiety without causing hallucinations. EB-003 is a neuroplastic and non-hallucinogenic N, N-Dimethyltryptamine (DMT) analog drug candidate., such as ataxia or hyperthermia.